SCHOOL OF MEDICINE
SCHOOL OF MEDICINE
SCHOOL OF MEDICINE
Transforming Diabetes Care: From Precision Medicine to Health Systems Innovation
An International Conference
October 9–10, 2025
NU School of Medicine,
5/1 Kerey and Zhanibek Khandar Str.,
Astana city, Republic of Kazakhstan
5/1 Kerey and Zhanibek Khandar Str.,
Astana city, Republic of Kazakhstan
Dive into NU world in Astana!
Join us in celebrating Nazarbayev University’s 15th Anniversary with a high-impact international conference that brings together world-renowned experts, researchers, clinicians, and policymakers to explore transformative solutions in diabetes care.
Conference Highlights
- Keynote Speakers from leading international academic and scientific institutions and international organizations.
- Cutting-edge Topics:
- From laboratory to patients and populations: Genomics and precision medicine
- Advances and innovation for improving care and health systems transformation
- How biomedical and technological innovation are disrupting diabetes care
- Interactive Sessions: Hands-on insulin pump school, AI tool demos, policy pitch competitions, and more.
Why Attend?
Showcase and share your diabetes-related research in a multidisciplinary setting
Build international networks with leading academics, policy institutions, and international health organizations
Contribute to change: Help shape Kazakhstan’s and global strategies for diabetes prevention and care
Call for Abstracts Now Open
We welcome abstracts on a broad range of topics including but not limited to:
📬 Submit your abstract here or send it to: diabetes-kz.org@nu.edu.kz
📄 Abstract Guidelines: Max 300 words, include background, methods, results, and conclusion.
- Epidemiology of diabetes in LMICs
- Digital health innovations
- Patient-centered and community-based care
- Advances in clinical treatment and management
- AI and machine learning in diabetic complications
📬 Submit your abstract here or send it to: diabetes-kz.org@nu.edu.kz
📄 Abstract Guidelines: Max 300 words, include background, methods, results, and conclusion.
Who Should Attend
- Clinical and academic professionals in diabetes and endocrinology01
- Public health researchers and policymakers02
- Digital health and AI developers03
- Graduate students and early-career researchers04
- Industry representatives from pharma and med-tech sectors05